, an African healthtech accelerator, unveiled 3 partnerships at its 3rd Access to Markets (A2M) event){kind=link}
Investing in Innovation Africa (i3), a leading African healthtech accelerator, unveiled three transformative partnerships at its 3rd Access to Markets (A2M) event, highlighting the growing influence of African startups in healthcare innovation.
The deals, signed during a two-day gathering of investors, global pharmaceutical manufacturers, and government agencies, target cervical cancer prevention, pharmacy based access, and malaria care, areas of critical public health need across the continent.
MSD and digital platform MYDAWA announced a collaboration to expand concierge healthcare services to support cervical cancer elimination. The initiative combines at home and in clinic care with online booking and patient education, leveraging MSD’s business and technical expertise to scale patient centered solutions.
“We are meeting communities where they are, forging new paths for patient access. This is how we break down barriers across Africa,” said Dr. Priya Agrawal, MSD Vice President, International Health Equity and Partnerships.
In Nigeria, Sproxil partnered with the National Malaria Elimination Programme (NMEP) and the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) to deploy AI enhanced malaria surveillance. The model delivers real time insights from pharmacies and medicine vendors, allowing government agencies to monitor distribution and disease patterns while improving access to diagnostics and treatments.
“African led solutions, when properly supported, can drive continental health transformation while ensuring affordable anti-malarials reach the children and families who need them most,” said Dr. Ashifi Gogo, Sproxil CEO.
Boehringer Ingelheim’s Social Engagement Fund also invested in three startups, Dawa Mkononi, Kasha, and Reach52, further strengthening pharmacy innovation across Africa.
Since July, i3 has facilitated over 110 tailored introductions between startups and investors, generating 15 partnerships valued at more than $20 million. Its portfolio startups already serve 66,000 healthcare providers across 12 African countries and are projected to reach 167,000 providers by 2028.
Backed by the Gates Foundation, MSD, Cencora, Endless Health, HELP Logistics, Sanofi, and Boehringer Ingelheim, i3 continues to position Africa’s healthtech sector as a scalable, digitally enabled solution for pressing healthcare challenges.